ChemicalBook >> CAS DataBase List >>Pioglitazone (potassium salt)

Pioglitazone (potassium salt)

CAS No.
1266523-09-4
Chemical Name:
Pioglitazone (potassium salt)
Synonyms
Pioglitazone potassium;Pioglitazone (potassium salt);potassium:5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidin-3-ide-2,4-dione
CBNumber:
CB32592012
Molecular Formula:
C19H21KN2O3S
Molecular Weight:
396.55
MDL Number:
MOL File:
1266523-09-4.mol
MSDS File:
SDS
Last updated:2025-04-18 09:52:07

Pioglitazone (potassium salt) Properties

storage temp. Store at -20°C
solubility DMF: 30 mg/ml; DMSO: 10 mg/ml; Ethanol: 10 mg/ml
form A crystalline solid
FDA UNII X1ZX7RX9WU

Pioglitazone (potassium salt) price More Price(9)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 10028 Pioglitazone (potassium salt) ≥98% 1266523-09-4 1mg $32 2026-04-30 Buy
Cayman Chemical 10028 Pioglitazone (potassium salt) ≥98% 1266523-09-4 5mg $63 2026-04-30 Buy
Cayman Chemical 10028 Pioglitazone (potassium salt) ≥98% 1266523-09-4 10mg $110 2026-04-30 Buy
Cayman Chemical 10028 Pioglitazone (potassium salt) ≥98% 1266523-09-4 50mg $427 2026-04-30 Buy
aablocks AA009BLU Pioglitazone (potassium salt) ≥98% 1266523-09-4 1mg $32 2026-05-28 Buy
Product number Packaging Price Buy
10028 1mg $32 Buy
10028 5mg $63 Buy
10028 10mg $110 Buy
10028 50mg $427 Buy
AA009BLU 1mg $32 Buy

Pioglitazone (potassium salt) Chemical Properties, Uses, Production

Uses

Pioglitazone (U 72107) potassium is an orally active and selective PPARγ (peroxisome proliferator-activated receptor) agonist with high affinity binding to the PPARγ ligand-binding domain with EC50 of 0.93 μM and 0.99 μM for human and mouse PPARγ, respectively. Pioglitazone potassium can be used in diabetes research[2][3][4].

in vivo

Pioglitazone potassium (oral gavage, 10 or 30 mg/kg, once daily, 14 days) can induce improvements in insulin resistance and diabetes that may be lipocalin-dependent in the liver but not in skeletal muscle[3].
Pioglitazone potassium (oral gavage, 10 mg/kg, once daily, 4 weeks) can significantly reduce body weight (BW), cardiac hypertrophy, elevated blood glucose levels and improve the associated dyslipidemia[4].

Animal Model:ob/ob and adipo-/- ob/ob mice with a C57Bl/6 background[3]
Dosage:10 or 30 mg/kg
Administration:Oral gavage; once daily; 14 days
Result:Showed no changes of serum-free fatty acid and triglyceride levels as well as adipocyte sizes in ob/ob and adipo-/- ob/ob C57BL/6 mice at 10 mg/kg but significantly reduced to a similar degree at 30 mg/kg.
Also showed no changes of expressions of TNFα and resistin in adipose tissues of ob/ob and adipo-/- ob/ob mice at 10 mg/kg but decreased at 30 mg/kg.
Animal Model:Male Wistar albino rats[4]
Dosage:10 mg/kg
Administration:Oral gavage; once daily; 4 weeks
Result:Decreased the elevated serum levels of both creatinine and creatine kinase-MB (CK-MB), TGF-β1 gene expression and regulated the expression of MMP-2/TIMP-2 system.

IC 50

mouse PPARγ: 0.99 μM (EC50); h-PPARγ: 0.93 μM (EC50); hPPARδ: 43 μM (EC50); hPPARα: 100 μM (EC50); mouse PPARα: 100 μM (EC50)

References

[1] Kenji Kuwabara, et al. A novel selective peroxisome proliferator-activated receptor alpha agonist,2-methyl-c-5-[4-[5-methyl-2-(4-methylphenyl)-4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220), potently decreases plasma triglyceride and glucose levels and modifies lipoprotein profiles in KK-Ay mice. J Pharmacol Exp Ther. 2004 Jun;309(3):970-7. DOI:10.1124/jpet.103.064659
[2] A Puddu, et al. Pioglitazone attenuates the detrimental effects of advanced glycation end-products in the pancreatic beta cell line HIT-T15. Regul Pept. 2012 Aug 20;177(1-3):79-84. DOI:10.1016/j.regpep.2012.05.089
[3] Naoto Kubota, et al. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J Biol Chem. 2006 Mar 31;281(13):8748-55. DOI:10.1074/jbc.M505649200
[4] Rania A Elrashidy, et al. Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathy. J Cardiovasc Pharmacol Ther. 2012 Sep;17(3):324-33. DOI:10.1177/1074248411431581

Pioglitazone (potassium salt) Preparation Products And Raw materials

Raw materials

Preparation Products

Pioglitazone (potassium salt) Suppliers

Global Suppliers ( 11)
Supplier Tel Email Country ProdList Advantage
BOC Sciences 1-631-485-4226; 16314854226 info@bocsci.com United States 9920 65
Shanghai Hongye Biotechnology Co. Ltd 400-9205774 400-920-5774 sales@glpbio.cn China 6705 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767 sales@chemegen.com China 11123 58
Zhejiang Huida Biotech Co., LTD 0571-89903022 18679456698 zilong@hizyme.com China 8001 58
TargetMol Chemicals Inc. 4008200310 15002144251 marketing@tsbiochem.com China 24951 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11963 58
Pioglitazone (potassium salt) potassium:5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidin-3-ide-2,4-dione Pioglitazone potassium 1266523-09-4